BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9614354)

  • 1. Contribution of type II phospholipase A2 to in vitro phospholipase A2 enzymatic activity in human term placenta.
    Rice GE; Wong MH; Farrugia W; Scott KF
    J Endocrinol; 1998 Apr; 157(1):25-31. PubMed ID: 9614354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta.
    Farrugia W; Rice GE; Wong MH; Scott KF; Brennecke SP
    J Endocrinol; 1997 Apr; 153(1):151-7. PubMed ID: 9157179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes.
    Aitken MA; Farrugia W; Wong MH; Scott KF; Brennecke SP; Rice GE
    Biochim Biophys Acta; 1993 Nov; 1170(3):314-20. PubMed ID: 8218351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of type II phospholipase A2 messenger RNA and immunoactivity in human placenta and fetal membranes.
    Aitken MA; Thomas T; Brennecke SP; Scott KF; Rice GE
    Placenta; 1996 Sep; 17(7):423-9. PubMed ID: 8899871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term.
    Munns MJ; Farrugia W; King RG; Rice GE
    Placenta; 1999 Jan; 20(1):21-6. PubMed ID: 9950141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term.
    Freed KA; Moses EK; Brennecke SP; Rice GE
    Mol Hum Reprod; 1997 Jun; 3(6):493-9. PubMed ID: 9239738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II phospholipase A2 in human gestational tissues: subcellular distribution of placental immuno- and catalytic activity.
    Farrugia W; Aitken MA; van Dunné F; Wong MH; Brennecke SP; Scott KF; Rice GE
    Biochim Biophys Acta; 1993 Feb; 1166(1):77-83. PubMed ID: 8431495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of type II PLA2 to prostaglandin formation: a study using a type II PLA2 specific inhibitor SB 203347.
    Munns MJ; King RG; Rice GE
    Prostaglandins Other Lipid Mediat; 1999 Jul; 57(5-6):361-70. PubMed ID: 10480490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory type II phospholipase A2 and the generation of intrauterine signals.
    Rice GE
    Reprod Fertil Dev; 1995; 7(6):1471-9. PubMed ID: 8743149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial endotoxin increases type II phospholipase A2 immunoreactive content and phospholipase A2 enzymatic activity in human choriodecidua.
    Nguyen HT; Rice GE; Farrugia W; Wong M; Brennecke SP
    Biol Reprod; 1994 Mar; 50(3):526-34. PubMed ID: 8167224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide inhibition of type II phospholipase A2 expression, release and activity in vitro.
    Lappas M; Munns MJ; King RG; Rice GE
    Placenta; 2001 May; 22(5):418-24. PubMed ID: 11373152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative abundance of human placental phospholipase A2 messenger RNA in late pregnancy.
    Aitken MA; Rice G; Brennecke S
    Prostaglandins; 1992 Apr; 43(4):361-70. PubMed ID: 1376934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bacterial endotoxin on the in vitro release of Type II phospholipase-A2 and prostaglandin E2 from human placenta.
    Farrugia W; Nicholls L; Rice GE
    J Endocrinol; 1999 Feb; 160(2):291-6. PubMed ID: 9924199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranes exert indirect negative control on phospholipase A2 in human placenta.
    Buhl WJ; Zipfel M; Garcia MT; Eisenlohr LM; Gehring U
    Eicosanoids; 1991; 4(4):235-44. PubMed ID: 1790000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental maturation of baboon placental trophoblast: expression of messenger ribonucleic acid and protein levels of cytosolic and secretory phospholipases A2.
    Rosenthal MD; Albrecht ED; Pepe GJ
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2861-7. PubMed ID: 9709960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II phospholipase A2 in preterm human gestational tissues.
    Lappas M; Permezel M; Georgiou HM; Rice GE
    Placenta; 2001 Jan; 22(1):64-9. PubMed ID: 11162354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase A2 isozymes in pregnancy and parturition.
    Lappas M; Rice GE
    Prostaglandins Leukot Essent Fatty Acids; 2004 Feb; 70(2):87-100. PubMed ID: 14683686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory component in human amniotic fluid and gestational tissues: a potential endogenous phospholipase A2 inhibitor.
    Bennett WA; Allbert JR; Brackin MN; Morrison JC; Cowan BD
    J Soc Gynecol Investig; 1999; 6(6):311-7. PubMed ID: 10643584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of phospholipase A2 release by elicited-peritoneal macrophage and its relationship to eicosanoid production.
    Marshall LA; Bolognese B; Roshak A
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):295-313. PubMed ID: 7812679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory phospholipases and membrane polishing.
    Rice GE
    Placenta; 1998 Jan; 19(1):13-20. PubMed ID: 9481780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.